We are the next generation technology company leveraging on 4D Bioprinting techniques to bring time and cost-efficient solutions for the cosmetic/pharma industrial R&D.

Momentum is derived from funding recency, velocity, round count and scale.

Other business activities

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.